Back to search

Article

ATF2 drives macrophage-mediated anti-PD-1 resistance by coupling KAT3A-dependent H3K18 lactylation with CCL2 transcription in hepatocellular carcinoma

2026-08-25

Abstract excerpt

<title>Abstract</title> <p>Immune checkpoint blockade has improved the treatment of hepatocellular carcinoma (HCC), yet most patients fail to achieve durable responses to PD-1 blockade. Tumor-associated macrophages are major determinants of immunotherapy resistance, but the tumor-intrinsic epigenetic programs that recruit and polarize macrophages in HCC remain incompletely defined. Here, we identify activating tr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1cffe443-050a-5ea6-b19d-af1633da6746
DOI
10.21203/rs.3.rs-10533707/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ATF2 drives macrophage-mediated anti-PD-1 resistance by coupling KAT3A-dependent H3K18 lactylation with CCL2 transcription in hepatocellular carcinomaDOI 10.21203/rs.3.rs-10533707/v1
Select a neighboring publication to make it the new centre.